RESPONSE OF MOUSE ORAL-MUCOSA TO REPEATED DOSES OF BLEOMYCIN

被引:0
作者
DORR, W
HONIG, M
机构
来源
ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B | 1994年 / 30B卷 / 05期
关键词
ORAL MUCOSA; BLM TOXICITY; TIME INTERVAL; DOSE-EFFECT CURVES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bleomycin (BLM) applied at systemically tolerable doses induces denudation of tongue mucosa in the C3H-Neuherberg mouse strain. The dose-incidence curve after single injections has a sigmoid shape with an EDS, Of 17.5 mg/kg. In contrast, the dose-response curves to repeated (two, five and 10) drug injections follow triphasic shapes and show dose-effect inversions. The effect initially increases with dose to a maximum of 70-100% at 2 x 7, 5 x 2, and 10 x 0.9 mg/kg. A marked decrease in response is observed at higher doses with a nadir of 10-30% after 2 x 11 mg/kg, 5 x 4 to 5 x 5 mg/kg and 10 x 2 mg/kg, followed by a second rise when dose is further increased. These clinical results were confirmed in a histological study. Variation of the time interval between two drug injections caused marked fluctuations in the treatment efficacy. A clear increase in drug response was induced by splitting total drug doses of 6, 14 or 22 mg/kg, the maximum effect (100%) was seen at interval of 2 h, 0.5-1 h and 0.25 h between two injections of 3, 7 or 11 mg/kg, respectively. At longer intervals of up to 6 h, a dose-dependent decrease in drug efficacy resulted in an inverse dose-effect. Original tissue tolerance to BLM was restored only in the 2 x 3 mg/kg arm but was still elevated in the other arms after 96 h. The results can be plausibly explained by the dose-dependent induction of detoxifying processes.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 32 条
[1]   BLEOMYCIN-RESISTANT CELLS CONTAIN INCREASED BLEOMYCIN-HYDROLASE ACTIVITIES [J].
AKIYAMA, S ;
IKEZAKI, K ;
KURAMOCHI, H ;
TAKAHASHI, K ;
KUWANO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 101 (01) :55-60
[2]  
BARRANCO SC, 1971, CANCER RES, V31, P1218
[3]   EFFECT OF BLEOMYCIN AND RADIATION IN COMBINATION ON BACTERIA AND MAMMALIAN-CELLS IN CULTURE [J].
BLEEHEN, NM ;
GILLIES, NE ;
TWENTYMAN, PR .
BRITISH JOURNAL OF RADIOLOGY, 1974, 47 (558) :346-351
[4]   PRELIMINARY-RESULTS OF A RANDOMIZED EORTC STUDY COMPARING RADIOTHERAPY AND CONCOMITANT BLEOMYCIN TO RADIOTHERAPY ALONE IN EPIDERMOID CARCINOMAS OF OROPHARYNX [J].
CACHIN, Y ;
JORTAY, A ;
SANCHO, H ;
ESCHWEGE, F ;
MADELAIN, M ;
DESAULTY, A ;
GERARD, P .
EUROPEAN JOURNAL OF CANCER, 1977, 13 (12) :1389-1395
[5]   PROLIFERATION KINETICS OF MOUSE TONGUE EPITHELIUM UNDER NORMAL CONDITIONS AND FOLLOWING SINGLE DOSE IRRADIATION [J].
DORR, W ;
KUMMERMEHR, J .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1991, 60 (05) :287-294
[6]   CAPACITY AND KINETICS OF SLD REPAIR IN MOUSE TONGUE EPITHELIUM [J].
DORR, W ;
BREITNER, A ;
KUMMERMEHR, J .
RADIOTHERAPY AND ONCOLOGY, 1993, 27 (01) :36-45
[7]   ACCELERATED REPOPULATION OF MOUSE TONGUE EPITHELIUM DURING FRACTIONATED IRRADIATIONS OR FOLLOWING SINGLE DOSES [J].
DORR, W ;
KUMMERMEHR, J .
RADIOTHERAPY AND ONCOLOGY, 1990, 17 (03) :249-259
[8]   THE COMBINED EFFECT OF BLEOMYCIN AND IRRADIATION ON MOUSE LIP MUCOSA .1. INFLUENCE OF TIMING, SEQUENCE AND MODE OF DRUG ADMINISTRATION WITH SINGLE DOSE IRRADIATION [J].
FENG, Y ;
VANUYTSEL, L ;
LANDUYT, W ;
ANG, KK ;
VANDERSCHUEREN, E .
RADIOTHERAPY AND ONCOLOGY, 1986, 6 (02) :143-151
[9]   ALTERATIONS IN PULMONARY PROTECTIVE ENZYMES FOLLOWING SYSTEMIC BLEOMYCIN TREATMENT IN MICE [J].
FILDERMAN, AE ;
GENOVESE, LA ;
LAZO, JS .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (06) :1111-1116
[10]   COMBINED RADIOTHERAPY AND CHEMOTHERAPY WITH BLEOMYCIN AND METHOTREXATE FOR ADVANCED INOPERABLE HEAD AND NECK-CANCER - UPDATE OF A NORTHERN CALIFORNIA ONCOLOGY GROUP RANDOMIZED TRIAL [J].
FU, KK ;
PHILLIPS, TL ;
SILVERBERG, IJ ;
JACOBS, C ;
GOFFINET, DR ;
CHUN, C ;
FRIEDMAN, MA ;
KOHLER, M ;
MCWHIRTER, K ;
CARTER, SK .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) :1410-1418